The global atherectomy devices market size is expected to reach USD 1,648.2 million by 2030, expanding at a CAGR of 8.1% from 2023 to 2030, according to a new report by Grand View Research, Inc. The demand for atherectomy devices market is anticipated to boost over the forecast period due to rapidly rising incidence of target diseases such as peripheral artery disease. Favorable patient outcomes with minimally invasive procedures is also driving demand of atherectomy devices for peripheral vascular interventions.
New technologies and product approvals are expected to boost the market for orbital and laser atherectomy devices over the forecast period. For instance, in July 2018, Cardiovascular Systems, Inc. (CSI) signed an agreement with Aerolase Corp. to co-develop a new laser atherectomy device. The agreement gave CSI an opportunity to leverage Aerolase’s FDA cleared proprietary laser technology. The new laser atherectomy system will be used for treating multiple forms of peripheral arterial diseases
Request a free sample copy or view report summary: Atherectomy Devices Market Report
In 2022, the directional atherectomy segment held the largest market share owing to their capability of collecting the shaved plaque in a collecting space, which reduces the risk of barotrauma, dissection, and neointimal hyperplasia.
Laser atherectomy devices is expected to the fastest growing segment over the next 8 years. Laser technique is perceived as to have more precision in plaque removal and cause fewer complications. It is also believed to result in lesser incidence of restenosis.
Geographically, North America held the largest market share in 2022 and is expected to maintain its position during the forecast period. A high prevalence of Peripheral Artery Diseases (PAD) in this region is one of the key reasons for high demand of atherectomy. Almost 8.5 million people suffer from PAD in the U.S., resulting in an annual economic burden of nearly USD 160 million.
Asia Pacific is anticipated to observe the fastest growth over the coming years. Improving economic conditions leading to increasing prevalence of lifestyle diseases, especially cardiovascular and peripheral, is the key reason for this growth.
Grand View Research has segmented the global atherectomy devices market based on type, and region:
Atherectomy Devices Type Outlook (Revenue, USD Million; 2018 - 2030)
Directional Atherectomy
Rotational Atherectomy
Orbital Atherectomy
Laser Atherectomy
Atherectomy Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East and Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Atherectomy Devices Market
Boston Scientific Corporation
Cardiovascular Systems, Inc.
Medtronic
Avinger
Koninklijke Philips N.V.
BD
Abbott
Cordis
Terumo Medical Corporation
"The quality of research they have done for us has been excellent..."